HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Promotes Clearblue Advanced Digital To Keep Ovulation Test Lead

This article was originally published in The Tan Sheet

Executive Summary

P&G launches a promotional campaign for the first digital test that can indicate a woman’s peak four days of ovulation under the Clearblue brand, which it markets for manufacturer SPD Swiss Precision Diagnostics.

You may also be interested in...



PLMA In Brief

Perrigo predictor: Private label firm unveils its Easy Ovulation Predictor, equivalent to Inverness Medical Innovations' Clearblue Easy, at the Private Label Manufacturers Association trade show Nov. 16-18 in Chicago. The seven-test kit will ship in January. Perrigo also launched adult low-strength aspirin, a national brand equivalent (NBE) to McNeil Consumer & Specialty Pharmaceutical's St. Joseph's. The 81 mg coated tablets come in a 180-count bottle. Separately, the Allegan, Mich.-based firm received approval this month for a product comparable to Aleve Cold & Sinus...

People In Brief

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

FDA Details “Quality Agreements” For Marketers, Contract Manufacturers

The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.

Topics

Related Companies

UsernamePublicRestriction

Register

RS124322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel